About 5 percent of people in any healthcare system will be diagnosed to carry one or more of what are called clinically actionable diseases, meaning something can be done about their genetic variant and disease condition," said Aziz. The latest generation of gene sequencers is driving innovation in precision medicine, according to Nazneen Aziz, executive director of Kaiser Permanente Research Bank. “Genomics has become a critical tool for the diagnosis and treatment of many diseases,” Aziz said.
The latest generation of gene sequencers is driving innovation in precision medicine, according to Nazneen Aziz, executive director of Kaiser Permanente Research Bank. “Genomics has become a critical tool for the diagnosis and treatment of many diseases,” Aziz said.